Somatotroph is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-09-04. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Regulatory approval in the United States came in 2010, when the Food and Drug Administration cleared the peptide for the reduction of excess abdominal fat in adults with HIV infection and associated lipodystrophy. The decision rested mainly on two randomized phase 3 trials that enrolled roughly eight hundred patients and ran for twenty-six weeks. Participants receiving active drug showed substantially greater declines in visceral adipose tissue than those receiving placebo, while total body weight changed comparatively little. A reformulated presentation was later approved, and the product has remained a niche therapy rather than a general weight-loss agent.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
Because growth hormone is released in pulses, single measurements can misrepresent overall secretion. Investigators sometimes use repeated sampling or overnight profiles to capture the pattern rather than a single value. Provocative testing, in which a stimulus is given and the response is tracked over time, offers another way to characterize the axis. Each approach carries trade-offs between sensitivity, burden on the participant, and the influence of non-target variables.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Dry food processing is popular in the pet food industry, as it is an efficient way to supply continuous production of feed in many varieties. It is energy efficient, allows for large amounts of feed to be used, and is cost effective. To make dog kibble, a process known as extrusion is done. A simple extruder consists of a barrel, helical screws, and a die (tool to cut and shape food). Feed ingredients are solid at room temperature; therefore, the extrusion process of these ingredients requires a temperature above 150 degrees Celsius, achieved by the use of steam, hot water, or other heat sources in order to soften or melt the mixture and allow for fluidity through the barrel. During the extrusion process, the high amounts of pressure applied to the mixture forces it to enter through the die before exiting the extruder completely, where it is cut to its desired size by a rotating fly knife. Unfortunately, the extrusion process actually denatures some of nutritional elements of the food. Taurine deficiency has been found in dogs and cats fed extruded commercial diets. Not usually considered an essential nutrient for dogs, taurine is plentiful in most whole meats, whether raw or cooked, but is reduced in extruded diets. Taurine deficiency could also be due to the use of rendered, highly processed meat sources that are low in taurine. Regardless of the cause, taurine is now artificially supplemented back into the diet after processing in the production of most commercial pet food.
Communication satellite – an artificial satellite used as a telecommunications relay to transmit data between widely separated points on Earth. These are used because the microwaves used for telecommunications travel by line of sight and so cannot propagate around the curve of the Earth. As of 1 January 2021, there were 2,224 communications satellites in Earth orbit. Most are in geostationary orbit 22,200 miles (35,700 km) above the equator, so that the satellite appears stationary at the same point in the sky, so the satellite dish antennas of ground stations can be aimed permanently at that spot and do not have to move to track it. In a satellite ground station a microwave transmitter and large satellite dish antenna transmit a microwave uplink beam to the satellite. The uplink signal carries many channels of telecommunications traffic, such as long-distance telephone calls, television programs, and internet signals, using a technique called frequency-division multiplexing (FDM). On the satellite, a transponder receives the signal, translates it to a different downlink frequency to avoid interfering with the uplink signal, and retransmits it down to another ground station, which may be widely separated from the first. There the downlink signal is demodulated and the telecommunications traffic it carries is sent to its local destinations through landlines. Communication satellites typically have several dozen transponders on different frequencies, which are leased by different users.
== Nanotechnology applications == Many potential applications have been suggested in literature, including enzyme immobilization, drug delivery systems, and nanotechnological self-assembly of materials. Though DNA is not the natural choice for building active structures for nanorobotic applications, due to its lack of structural and catalytic versatility, several papers have examined the possibility of molecular walkers on origami and switches for algorithmic computing. The following paragraphs list some of the reported applications conducted in the laboratories with clinical potential. In a study conducted by a group of scientists from iNANO center and CDNA Center at Aarhus university, researchers were able to construct a small multi-switchable 3D DNA Box Origami. The proposed nanoparticle was characterized by AFM, TEM and FRET. The constructed box was shown to have a unique reclosing mechanism, which enabled it to repeatedly open and close in response to a unique set of DNA or RNA keys. The authors proposed that this "DNA device can potentially be used for a broad range of applications such as controlling the function of single molecules, controlled drug delivery, and molecular computing."
{\displaystyle \mathbf {V} (f_{n},\tau _{n})={\begin{bmatrix}cos(\tau _{n}{\sqrt {f_{n})}}&1/{\sqrt {f_{n}}}sin(\tau _{n}{\sqrt {f_{n}}}\\-{\sqrt {f_{n}}}sin(\tau _{n}{\sqrt {f_{n}}})&cos(\tau _{n}{\sqrt {f_{n}}})\end{bmatrix}}\qquad f_{n}>0\qquad \qquad \qquad (3a)}
Sources: en.wikipedia.org
Nuclear transitions, including the 'isomeric' variety, occur not only through gamma-ray emission, but also internal conversion where the transition energy instead ejects an electron from the atom, and internal pair production where the transition energy creates an electron-positron pair that are then ejected from the atom. The two processes always compete, with gamma emission normally the most common, but as the proportion converted increases with lower energy and also with forbiddenness, it often becomes important for metastable isomers. In fact, the usual decay of 99m43Tc involves conversion to the spin-7/2 state, then prompt gamma emission to the spin-9/2 ground state; similarly, 180m73Ta could decay through conversion to the spin-2 state, followed by a gamma decay to the ground state. This gamma was looked for in, which assumed that to be the likely decay scheme, and not found. In isotopes whose ground state is unstable, isomers can decay by the same modes rather than going to the ground state. Often both are seen, but rates can differ so much that only one is. Both isomers discussed just above have unstable ground states: 9943Tc undergoes beta decay, though slowly (half-life 211 ky) due to forbiddenness, and the isomer, which is less so, beta-decays over 10,000 times faster (though still a small minority of decays); 18073Ta can fall to either beta decay or electron capture, and quickly (half-life 8.15 h) as it is not forbidden, there the isomer is much more so to either as well as to isomeric transition, explaining its stability.
There are two closely related lep paralogues in Atlantic salmon (Salmo salar). A single lep gene has been documented for green-spotted pufferfish (Tetraodon nigroviridis), rainbow trout (Oncorhynchus mykiss), Arctic charr (Salvelinus alpinus), silver carp (Hypophthalmichthys molitrix), and grass carp (Ctenopharyngodon idellus). In other species there are reports of two closely related lep paralogues, including common carp (Cyprinus carpio) and Atlantic salmon. More distantly related lep genes have been found in medaka (Oryzias latipes) and zebrafish (Danio rerio). At least 2 leptin genes (lepa and lepb) exist in the crown-clade (Fig. 1). Early findings have shown that lepa and lepb share low interspecies aa identity, and are argued to have arisen through whole genome duplication, which occurred early in the teleost lineage. The duplicity of genes has been described for Atlantic salmon, Japanese medaka, common carp and zebrafish. Both lep paralogues cluster with lepa, and therefore suggest that at least one or more form (lepb) may exist in this species, since it is tetraploid. However, previous attempts using genomic synteny have only found the putative genomic duplicates in medaka and zebrafish paralogue. Currently it remains unclear, whether lepb exists in other teleosts due to the degenerative nature of this paralogue.
Soy products such as tofu and tempeh, (which contain the inhibitor "genistein") Agaricus subrufescens mushrooms (contain the inhibitors sodium pyroglutamate and ergosterol) Black raspberry (Rubus occidentalis) extract Lingzhi mushrooms (via inhibition of VEGF and TGF-beta) Trametes versicolor mushrooms (Polysaccharide-K) Maitake mushrooms (via inhibition of VEGF) Phellinus linteus mushrooms (via active substance Interfungins A inhibition of glycation) Green tea (catechins) Liquorice (glycyrrhizic acid) Red wine (resveratrol) Antiangiogenic phytochemicals and medicinal herbs Royal jelly (queen bee acid)
=== Ruthenium tetroxide === Ruthenium tetroxide is equally volatile and even more aggressive than osmium tetraoxide and able to stain even materials that resist the osmium stain, e.g. polyethylene. Other chemicals used in electron microscopy staining include: ammonium molybdate, cadmium iodide, carbohydrazide, ferric chloride, hexamine, indium trichloride, lanthanum(III) nitrate, lead acetate, lead citrate, lead(II) nitrate, periodic acid, phosphomolybdic acid, potassium ferricyanide, potassium ferrocyanide, ruthenium red, silver nitrate, silver proteinate, sodium chloroaurate, thallium nitrate, thiosemicarbazide, uranyl acetate, uranyl nitrate, and vanadyl sulfate.
However, the evidence is poor quality relating to the treatment of uveitis, with the potential side effects (cataract progression and raised intraocular pressure) being significant, and the benefits not certainly greater than standard treatment. Dexamethasone has also been used with antibiotics to treat acute endophthalmitis. Dexamethasone is used in transvenous screw-in cardiac pacing leads to minimize the inflammatory response of the myocardium. The steroid is released into the myocardium as soon as the screw is extended and can play a significant role in minimizing the acute pacing threshold due to the reduction of inflammatory response. The typical quantity present in a lead tip is less than 1.0 mg. Dexamethasone may be administered before antibiotics in cases of bacterial meningitis. Gram-negative bacteria — to which the causative agent of bacterial meningitis, Neisseria meningitidis, belongs — have highly immunogenic lipopolysaccharides as a component of their cell membrane and trigger a strong inflammatory response. Pre-administration of dexamethasone before the administration of antibiotics acts to reduce that response, thus reducing hearing loss and neurological damage.
Sources: en.wikipedia.org
Cullen (1860), chief judge of the New York Court of Appeals Egerton Leigh Winthrop (1860), lawyer and socialite Emile Henry Lacombe (1863), judge on the United States Court of Appeals for the Second Circuit Henry Rutgers Beekman (1865), judge on the New York Supreme Court, former corporation counsel of New York City and parks commissioner George Goelet Kip (1865), lawyer, heir and member of the Goelet family George Gosman DeWitt (1867), lawyer, philanthropist, former president of the Saint Nicholas Society of the City of New York Nicholas Fish II (1867), attorney, diplomat, investment banker; son of United States Secretary of State Hamilton Fish Willard Bartlett (1869), chief judge of the New York Court of Appeals Lewis Cass Ledyard* (1871), personal counsel to J. P. Morgan and namesake partner of Carter Ledyard & Milburn, transferred to Harvard University after freshman year Frederic Bronson (1871), lawyer and treasurer for New York Life and Trust Company, grandson of American Revolutionary War surgeon Isaac Bronson Thomas C. Bach (1875), judge on the Supreme Court of the Territory of Montana Francis S. Bangs (1878), attorney at Bangs, Stetson, Tracy, and McVeigh and trustee of Columbia College Frederick William Holls (1878), lawyer, publicist, secretary of the United States delegation to the Hague Peace Conference Edward De Peyster Livingston (1882), lawyer and society leader during the Gilded Age Randolph B. Martine (1885), New York County district attorney 1885–1887 John Vernou Bouvier Jr.
=== Debridement === Debridement is defined as removal of devitalized or dead tissue, particularly necrotic tissue, eschar, or slough. Debridement is a critical aspect of wound care because devitalized tissue, particularly necrotic tissue, serves as nutrients for bacteria thereby promoting infection. Additionally, devitalized tissue creates a physical barrier over a wound which limits the effectiveness of any applied topical compounds and prevents re-epithelialization. Lastly, devitalized tissue, especially eschar, prevents accurate assessment of underlying tissue, making appropriate assessment of a wound impossible without adequate debridement. Debridement can be achieved in several ways:
==== Pharmacokinetics ==== Due to high lipid solubility, cannabidiol is poorly absorbed in the intestine. The absorbed cannabidiol accumulates in adipose tissue or albumin (proteins in blood), which prolongs its elimination from the body. Most absorbed cannabidiol is converted into other metabolites by various enzymes in the liver and intestine, including CYP2C19 and CYP3A4. Cannabidiol is mainly excreted from the body with faeces.
Steven Eugene Wilson (born 1951) is an American ophthalmologist and professor at Cleveland Clinic, where he is a surgeon and directs corneal research. He has also received honors for several published historical fiction novels. His research has focused on corneal cellular responses to injury and surgery, with his most-cited work being about keratocyte apoptosis, as well as cellular and molecular interactions involved in homeostasis, wound healing, and diseases of the cornea. He holds two United States patents related to corneal healing. He previously served as a professor and chair of the Department of Ophthalmology at the University of Washington in Seattle from 1998 to 2003, and was named Grace E. Hill Endowed Chair in Vision Research.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It varies slowly and reflects cumulative axis activity rather than momentary secretion. Growth hormone is released in pulses affected by sleep, stress, and meals, making single readings hard to interpret. The slower marker gives a more stable picture across a study period.